• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS - 3; NIP Back to Search Results
Catalog Number VBC081002
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problem Perforation of Vessels (2135)
Event Date 12/12/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).Imaging evaluation results.Intended use / indications state, the gore® viabahn® endoprosthesis is indicated for improving blood flow in patients with symptomatic peripheral arterial disease in superficial femoral artery lesions with reference vessel diameters ranging from 4.0 ¿ 7.5 mm.The gore® viabahn® endoprosthesis is indicated for improving blood flow in patients with symptomatic peripheral arterial disease in iliac artery lesions with reference vessel diameters ranging from 4.0 ¿ 12 mm.W.L.Gore & associates has insufficient clinical and experimental data upon which to base any conclusions regarding the effectiveness of the gore® viabahn® endoprosthesis in applications where the endoprosthesis may experience repeated and extreme flexion, such as across the popliteal fossa and the antecubital fossa.Clinical conditions such as excessive bending, tortuosity, and / or repeated and extreme flexion may result in compromised performance or failure of the endoprosthesis.
 
Event Description
It was reported to gore that a 8mm x 10cm gore® viabahn® endoprosthesis was to be implanted for treatment of the splenic artery aneurysm.Because of the excessively tortuous vessels, resistance was reportedly felt during device advancement.The splenic artery aneurysm was ruptured due to the excessive force used during attempts to get the viabahn device to treatment site.The constrained gore® viabahn® endoprosthesis was retracted out of the patient.Coiling was done to stop the bleeding and the patient was transferred to the icu for surgical intervention.The patient tolerated the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN® ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
vickie lang
9285263030
MDR Report Key8193428
MDR Text Key131306321
Report Number2017233-2018-00795
Device Sequence Number1
Product Code PFV
UDI-Device Identifier00733132614608
UDI-Public00733132614608
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial
Report Date 12/14/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/24/2018
Is this an Adverse Event Report? Yes
Device Operator Health Professional
Device Expiration Date03/06/2021
Device Catalogue NumberVBC081002
Device Lot Number18278635
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/07/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age60 YR
Patient Weight70
-
-